Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Hisamitsu One Step Closer to FY2019 Filing after NSAID Patch Delivers Positive PIII in Cancer Pain
May 27, 2019
- AbbVie’s Psoriasis Drug Skyrizi Makes Debut in Japan
May 27, 2019
- MSD’s Zerbaxa Launch Being Shelved after Foreign Particles Detected
May 27, 2019
- Big 3 Generic Makers Eke Out Growth in Japan, but Struggle in US; AG Momentum Continues: Jiho Tally
May 24, 2019
- Daiichi Sankyo Denies Report on Sales Deal on Its OTC Subsidiary
May 24, 2019
- Shionogi in Marketing Tie-Up with Molteni for Rizmoic
May 23, 2019
- Ono Offers Its Account of License Fee Row with Nobel Laureate
May 23, 2019
- Trelegy Hits Japan Shelves, Novartis Starts Accepting Orders for Kymriah
May 23, 2019
- AbbVie’s Japan Sales in 2018 Double on Maviret Boon
May 23, 2019
- Chugai to Set Up Research Base in Yokohama, Shutter 2 Labs
May 22, 2019
- Japan Pharma Market Shrinks 1.8% in FY2018: IQVIA
May 22, 2019
- 1st Oral Proceedings Held for Bayer Employee Damage Suit
May 21, 2019
- Oncolys Chief Wants Chugai Deal to Accelerate Telomelysin Development in Japan
May 21, 2019
- Daiichi Sankyo Returns Part of Govt Grant for H5N1 Influenza Vaccine Project after Missing Supply Target
May 21, 2019
- Taisho Completes Tender Offer for Vietnamese Drug Maker
May 21, 2019
- Reducing Production Cost of Stemirac Is Key Issue: Nipro Pres.
May 20, 2019
- Top 4 Wholesalers See Over 1% Operating Margins in FY2018, Thanks Partly to Distribution Improvement Guidelines
May 20, 2019
- Ribomic Confident in Efficacy Outcome of Upcoming PII of Wet-AMD Treatment with Just 40 Patients: Pres.
May 20, 2019
- Fuji Pharma to File Biosimilars for Japan Approval by 2021: President
May 20, 2019
- JCR to License Lysosome Storage Disease Treatment to Global Player by March 2020: Chairman
May 20, 2019
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…